4.7 Article

Aiming for the Ideal Synthesis

Journal

JOURNAL OF ORGANIC CHEMISTRY
Volume 75, Issue 14, Pages 4657-4673

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/jo1006812

Keywords

-

Funding

  1. Scripps Research Institute
  2. Skaggs Institute for Chemical Biology
  3. NIH
  4. NSF
  5. Alfred P. Sloan Foundation
  6. Austrian Science Foundation (FWF) [J2899]
  7. Amgen
  8. Bristol-Myers Squibb
  9. Pfizer
  10. Roche
  11. GlaxoSmithKline
  12. Astra Zeneca
  13. Dupont
  14. Searle Foundation
  15. Beckmann Foundation
  16. Austrian Science Fund (FWF) [J2899] Funding Source: Austrian Science Fund (FWF)

Ask authors/readers for more resources

The field of total synthesis has a rich history and a vibrant future. Landmark advances and revolutionary strides in the logic of synthesis have put the practicing chemist in the enviable position of being able to create nearly any molecule with enough time and effort. The stage is now set for organic chemists to aim for ideality in the way molecules are synthesized. This perspective presents a simple and informative definition of ideality and demonstrates its use during the self-evaluation of several syntheses from our laboratory.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available